We are live on ! Find out more
HKAM

Horizon Kinetics Asset Management Portfolio holdings

AUM $9.23B
1-Year Est. Return 27.52%
This Fund
S&P 500
This Quarter Est. Return
-2.61%
1 Year Est. Return
+27.52%
3 Year Est. Return
+184.83%
5 Year Est. Return
+256.84%
10 Year Est. Return
AUM
$4.78B
AUM Growth
-$274M
Cap. Flow
-$283M
Cap. Flow %
-5.93%
Top 10 Hldgs %
71.54%
Holding
347
New
16
Increased
48
Reduced
178
Closed
22

Sector Composition

Rank Sector Weight
1 Energy 50.01%
2 Financials 8.8%
3 Materials 8.65%
4 Consumer Discretionary 4.73%
5 Technology 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
301
Pacific Biosciences
PACB
$370M
$113K ﹤0.01%
11,517
-483
-4% -$3.95K
VNDA icon
302
Vanda Pharmaceuticals
VNDA
$302M
$109K ﹤0.01%
25,912
-1,088
-4% -$4.39K
VTN icon
303
Invesco Trust for Investment Grade New York Municipals
VTN
$168M
$108K ﹤0.01%
10,414
NMZ icon
304
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.22B
$102K ﹤0.01%
10,369
NUV icon
305
Nuveen Municipal Value Fund
NUV
$1.91B
$99.3K ﹤0.01%
11,550
OIS icon
306
Oil States International
OIS
$491M
$91.7K ﹤0.01%
13,511
-4,520
-25% -$32.7K
GALT icon
307
Galectin Therapeutics
GALT
$348M
$89.2K ﹤0.01%
53,742
-2,258
-4% -$4.38K
TSVT
308
DELISTED
2seventy bio
TSVT
$73.8K ﹤0.01%
17,275
-725
-4% -$2.23K
ALLO icon
309
Allogene Therapeutics
ALLO
$694M
$61.6K ﹤0.01%
19,194
-806
-4% -$2.29K
TTI icon
310
TETRA Technologies
TTI
$1.26B
$61.5K ﹤0.01%
13,600
-5,440
-29% -$27.5K
KEEL
311
Keel Infrastructure Corp
KEEL
$2.34B
$53.3K ﹤0.01%
18,300
BLUE
312
DELISTED
bluebird bio
BLUE
$50.3K ﹤0.01%
1,823
-77
-4% -$4.7K
VVR icon
313
Invesco Senior Income Trust
VVR
$454M
$41K ﹤0.01%
10,000
RAIN
314
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$28.8K ﹤0.01%
23,992
-1,008
-4% -$1.09K
DCOY
315
Decoy Therapeutics
DCOY
$2.09M
$20.2K ﹤0.01%
22
-1
-4% -$998
MANA
316
DELISTED
MANATRON INC
MANA
$11.5K ﹤0.01%
691
NCNA
317
NuCana
NCNA
$6.12M
$5.76K ﹤0.01%
4
TCRT icon
318
Alaunos Therapeutics
TCRT
$4.86M
$2.4K ﹤0.01%
227
BELFA icon
319
Bel Fuse Inc Class A
BELFA
$3.37B
-7,691
Closed -$357K
BELFB
320
Bel Fuse Inc Class B
BELFB
$4.21B
-28,988
Closed -$1.38M
BR icon
321
Broadridge
BR
$19B
-4,564
Closed -$817K
CBRE icon
322
CBRE Group
CBRE
$42.9B
-277,434
Closed -$20.5M
CQP icon
323
Cheniere Energy
CQP
$31.3B
-4,000
Closed -$217K
D icon
324
Dominion Energy
D
$59.3B
-5,350
Closed -$239K
EFXT
325
Enerflex
EFXT
$2.44B
-11,655
Closed -$66.8K

Similar funds

Horizon Kinetics Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Horizon Kinetics Asset Management held 347 positions worth $4.78B, down 5.4% from $5.05B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Horizon Kinetics Asset Management withdrew a net $283M in Q4 2023, closing 22 positions and reducing 178 holdings. Its most notable exit was CBRE Group, an estimated $20.5M position sold in full.

By sector, the portfolio is most concentrated in Energy at 50% of assets, down from 57% a quarter earlier, followed by Financials and Materials.

Against the trend, Horizon Kinetics Asset Management opened a new position in Eagle Materials worth $4.08M.

  • Horizon Kinetics Asset Management's largest Q4 2023 buy was Eagle Materials: 20,126 shares worth $4.08M.
  • Horizon Kinetics Asset Management added most to Vanguard Extended Market ETF in Q4 2023, an estimated $675K increase.
  • Horizon Kinetics Asset Management's biggest Q4 2023 reduction was Texas Pacific Land, cutting an estimated $71.3M.
  • Horizon Kinetics Asset Management fully exited CBRE Group in Q4 2023, selling an estimated $20.5M.
  • Horizon Kinetics Asset Management's ten largest holdings make up 72% of its $4.78B portfolio in Q4 2023.
  • Horizon Kinetics Asset Management opened 16 new positions and closed 22 in Q4 2023.
  • Horizon Kinetics Asset Management's portfolio value fell 5.4% quarter-over-quarter to $4.78B.

Based on Horizon Kinetics Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.